Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.

Lewiecki, E Michael; Keaveny, Tony M; Kopperdahl, David L; Genant, Harry K; Engelke, Klaus; Fuerst, Thomas; Kivitz, Alan; Davies, Richard Y; Fitzpatrick, Lorraine A.
J Clin Endocrinol Metab; 94(1): 171-80, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18840641